Zhiduan Cai

881 total citations
34 papers, 619 citations indexed

About

Zhiduan Cai is a scholar working on Pulmonary and Respiratory Medicine, Molecular Biology and Cancer Research. According to data from OpenAlex, Zhiduan Cai has authored 34 papers receiving a total of 619 indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Pulmonary and Respiratory Medicine, 16 papers in Molecular Biology and 12 papers in Cancer Research. Recurrent topics in Zhiduan Cai's work include Prostate Cancer Treatment and Research (9 papers), Cancer, Hypoxia, and Metabolism (8 papers) and Ureteral procedures and complications (7 papers). Zhiduan Cai is often cited by papers focused on Prostate Cancer Treatment and Research (9 papers), Cancer, Hypoxia, and Metabolism (8 papers) and Ureteral procedures and complications (7 papers). Zhiduan Cai collaborates with scholars based in China, United States and Macao. Zhiduan Cai's co-authors include Weide Zhong, Zezhen Liu, Yangjia Zhuo, Yuxiang Liang, Zhaodong Han, Cong Wang, Yongding Wu, Xuejin Zhu, Yulin Deng and Chin‐Lee Wu and has published in prestigious journals such as Cancer Research, Scientific Reports and Chemical Engineering Journal.

In The Last Decade

Zhiduan Cai

30 papers receiving 612 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Zhiduan Cai China 15 400 254 185 79 66 34 619
Caixia Wang China 14 281 0.7× 168 0.7× 103 0.6× 64 0.8× 53 0.8× 30 491
Julian Musa Germany 8 334 0.8× 136 0.5× 108 0.6× 113 1.4× 42 0.6× 18 500
Qiumeng Yang China 11 349 0.9× 209 0.8× 104 0.6× 125 1.6× 66 1.0× 17 598
Hironari Nishizawa Japan 11 445 1.1× 243 1.0× 337 1.8× 84 1.1× 36 0.5× 20 672
Chenghao Wang China 11 357 0.9× 261 1.0× 65 0.4× 106 1.3× 37 0.6× 34 599
Elisabeth Smolle Austria 12 329 0.8× 237 0.9× 154 0.8× 146 1.8× 22 0.3× 21 639
Jingping Ge China 18 546 1.4× 417 1.6× 101 0.5× 71 0.9× 32 0.5× 40 719
Hongzhi Zou United States 6 489 1.2× 146 0.6× 137 0.7× 101 1.3× 155 2.3× 8 700
Elisabetta Carico Italy 14 336 0.8× 210 0.8× 142 0.8× 157 2.0× 42 0.6× 39 683

Countries citing papers authored by Zhiduan Cai

Since Specialization
Citations

This map shows the geographic impact of Zhiduan Cai's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Zhiduan Cai with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Zhiduan Cai more than expected).

Fields of papers citing papers by Zhiduan Cai

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Zhiduan Cai. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Zhiduan Cai. The network helps show where Zhiduan Cai may publish in the future.

Co-authorship network of co-authors of Zhiduan Cai

This figure shows the co-authorship network connecting the top 25 collaborators of Zhiduan Cai. A scholar is included among the top collaborators of Zhiduan Cai based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Zhiduan Cai. Zhiduan Cai is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Cai, Zhiduan, et al.. (2024). Use of a Memokath™ 045 temperature-controlled memory alloy stent for treating upper renal calyx calyceal neck atresia: a case report. Journal of International Medical Research. 52(8). 3649335519–3649335519.
3.
Khan, Shahid Ali, Hao Lü, Jie Wang, et al.. (2024). Biocompatible, biodegradable, and anticancer alginate-quercetin ureteral stent via co-axial extrusion technique. International Journal of Biological Macromolecules. 287. 138545–138545.
4.
Chen, Haoyu, et al.. (2024). Mitochondrial dynamics and mitochondrial autophagy: Molecular structure, orchestrating mechanism and related disorders. Mitochondrion. 75. 101847–101847. 33 indexed citations
5.
Deng, Yulin, Zhiduan Cai, Huichan He, et al.. (2024). ACOX2 Serves as a Favorable Indicator Related to Lipid Metabolism and Oxidative Stress for Biochemical Recurrence in Prostate Cancer. Journal of Cancer. 15(10). 3010–3023. 7 indexed citations
6.
Xu, Yuyu, et al.. (2024). Risk factors for migration of retrievable covered expandable metallic stent in patients with persistent benign ureter strictures. World Journal of Urology. 42(1). 273–273. 1 indexed citations
7.
Cai, Zhiduan, Haoran Wang, Rui Zhu, et al.. (2024). MFN2 suppresses the accumulation of lipid droplets and the progression of clear cell renal cell carcinoma. Cancer Science. 115(6). 1791–1807. 7 indexed citations
8.
Ye, Jian‐Heng, Yuanfa Feng, Zhiduan Cai, et al.. (2023). Metformin escape in prostate cancer by activating the PTGR1 transcriptional program through a novel super-enhancer. Signal Transduction and Targeted Therapy. 8(1). 303–303. 12 indexed citations
9.
Han, Zhaodong, Rujun Mo, Yuanfa Feng, et al.. (2022). Differential Expression of E2F Transcription Factors and Their Functional and Prognostic Roles in Human Prostate Cancer. Frontiers in Cell and Developmental Biology. 10. 831329–831329. 14 indexed citations
10.
Liu, Ren, Yuanfa Feng, Yulin Deng, et al.. (2021). A HIF1α-GPD1 feedforward loop inhibits the progression of renal clear cell carcinoma via mitochondrial function and lipid metabolism. Journal of Experimental & Clinical Cancer Research. 40(1). 188–188. 37 indexed citations
11.
Liang, Yuxiang, et al.. (2021). The ALDOA Metabolism Pathway as a Potential Target for Regulation of Prostate Cancer Proliferation. OncoTargets and Therapy. Volume 14. 3353–3366. 15 indexed citations
12.
Ye, Jian‐Heng, Zhiduan Cai, Yong Luo, et al.. (2020). GPD1 Enhances the Anticancer Effects of Metformin by Synergistically Increasing Total Cellular Glycerol-3-Phosphate. Cancer Research. 80(11). 2150–2162. 51 indexed citations
13.
Zhang, Hui, Shaoyou Liu, Weimin Dong, et al.. (2020). Down-regulation of ACACA suppresses the malignant progression of Prostate Cancer through inhibiting mitochondrial potential. Journal of Cancer. 12(1). 232–243. 23 indexed citations
14.
Cai, Zhiduan, Yangjia Zhuo, Ming Xi, et al.. (2020). Overexpression of SLC6A1 associates with drug resistance and poor prognosis in prostate cancer. BMC Cancer. 20(1). 289–289. 9 indexed citations
15.
Song, Wan, Ming Xi, Haibo Zhao, et al.. (2019). HMGCS2 functions as a tumor suppressor and has a prognostic impact in prostate cancer. Pathology - Research and Practice. 215(8). 152464–152464. 25 indexed citations
16.
Jia, Zhenyu, Jianguo Zhu, Yangjia Zhuo, et al.. (2019). Offsetting Expression Profiles of Prognostic Markers in Prostate Tumor vs. Its Microenvironment. Frontiers in Oncology. 9. 539–539. 7 indexed citations
17.
Liu, Junchen, Guo Chen, Zezhen Liu, et al.. (2018). Aberrant FGFR Tyrosine Kinase Signaling Enhances the Warburg Effect by Reprogramming LDH Isoform Expression and Activity in Prostate Cancer. Cancer Research. 78(16). 4459–4470. 88 indexed citations
18.
Zhuo, Yangjia, Yu Zheng, Rujun Mo, et al.. (2017). High expression of ASPM correlates with tumor progression and predicts poor outcome in patients with prostate cancer. International Urology and Nephrology. 49(5). 817–823. 41 indexed citations
19.
Luo, Hongwei, Yueping Wan, Guanxing Chen, et al.. (2016). Protein regulator of cytokinesis 1 overexpression predicts biochemical recurrence in men with prostate cancer. Biomedicine & Pharmacotherapy. 78. 116–120. 22 indexed citations
20.
Zhong, Weide, Xin Fu, Guo Chen, et al.. (2016). Overexpression of BUB1B contributes to progression of prostate cancer and predicts poor outcome in patients with prostate cancer. OncoTargets and Therapy. 9. 2211–2211. 93 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Caixia Wang Breakdown of academic impact, for papers by Julian Musa Breakdown of academic impact, for papers by Qiumeng Yang Breakdown of academic impact, for papers by Hironari Nishizawa Breakdown of academic impact, for papers by Chenghao Wang Breakdown of academic impact, for papers by Elisabeth Smolle Breakdown of academic impact, for papers by Jingping Ge Breakdown of academic impact, for papers by Hongzhi Zou Breakdown of academic impact, for papers by Elisabetta Carico
Rankless by CCL
2026